WHO Model List
simvastatin
International nonproprietary name (English: simvastatin). Brand names vary by country.
Indications retained by WHO
Mixed hyperlipidaemia; Coronary atherosclerosis; Polycystic ovary syndrome.
Listed forms and strengths
- Oral > Solid: 5 mg; 10 mg; 20 mg; 40 mg
- Oral > Solid: 20 mg
Forms retained in the model list; presentations available in each country may differ.
General information from the WHO list. It replaces neither the prescription nor the leaflet: dosage and duration are for the doctor or pharmacist to decide.
Source: WHO electronic Essential Medicines List (2025 edition), checked on 13/11/2026. An error or an imprecision? Let us know